von Wasielewski R - Search Results

1

[The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas].

Länger F, von Wasielewski R, Kreipe HH. Länger F, et al. Among authors: von wasielewski r. Pathologe. 2006 Jul;27(4):244-50. doi: 10.1007/s00292-006-0836-z. Pathologe. 2006. PMID: 16758167 Review. German.

2

[Interlaboratory trial 2000 " Immunohistochemistry" of the German Society for Pathology and the Professional Association of German Pathologists].

Rüdiger T, Höfler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach E, Fischer HP, Mengel M, Von Wasielewski R, Müller-Hermelink K; German Society for Pathology; Professional Association of German Pathologists. Rüdiger T, et al. Among authors: von wasielewski r. Pathologe. 2003 Feb;24(1):70-8. doi: 10.1007/s00292-002-0595-4. Epub 2003 Jan 17. Pathologe. 2003. PMID: 12601481 German.

3

[Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

von Wasielewski R, Klöpper K, Lück HJ, Kreipe H. von Wasielewski R, et al. Pathologe. 2006 Sep;27(5):337-45. doi: 10.1007/s00292-006-0855-9. Pathologe. 2006. PMID: 16896675 German.

4

[Interlaboratory trials for quality assurance of breast cancer biomarkers in Germany].

Krusche CA, von Wasielewski R, Rüschoff J, Fisseler-Eckhoff A, Kreipe HH. Krusche CA, et al. Among authors: von wasielewski r. Pathologe. 2008 Jul;29(4):315-20. doi: 10.1007/s00292-008-1004-4. Pathologe. 2008. PMID: 18504581 German.

5

[Quality assurance in diagnostic in situ hybridization-experience of QuIP].

Jöhrens K, von Wasielewski R, Kreipe HH, Forberger A, Jurmeister P, Dietel M, Stenzinger A, Fischer J. Jöhrens K, et al. Among authors: von wasielewski r. Pathologe. 2020 Nov;41(6):614-620. doi: 10.1007/s00292-020-00832-6. Pathologe. 2020. PMID: 32945916 Review. German.

6

Beyond typing and grading: target analysis in individualized therapy as a new challenge for tumour pathology.

Kreipe HH, von Wasielewski R. Kreipe HH, et al. Among authors: von wasielewski r. Recent Results Cancer Res. 2007;176:3-6. doi: 10.1007/978-3-540-46091-6_1. Recent Results Cancer Res. 2007. PMID: 17607911

7

[Tissue-based markers of prognosis in breast cancer].

Kreipe H, von Wasielewski R. Kreipe H, et al. Among authors: von wasielewski r. Verh Dtsch Ges Pathol. 2005;89:52-8. Verh Dtsch Ges Pathol. 2005. PMID: 18035673 German.

8

Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.

Mengel M, von Wasielewski R, Wiese B, Rüdiger T, Müller-Hermelink HK, Kreipe H. Mengel M, et al. Among authors: von wasielewski r. J Pathol. 2002 Nov;198(3):292-9. doi: 10.1002/path.1218. J Pathol. 2002. PMID: 12375261 Clinical Trial.

9

Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer.

Mengel M, Hebel K, Kreipe H, von Wasielewski R. Mengel M, et al. Among authors: von wasielewski r. Breast J. 2005 Jan-Feb;11(1):34-40. doi: 10.1111/j.1075-122X.2005.21445.x. Breast J. 2005. PMID: 15647076

10

Prognostic impact of Skp2 and p27 in human breast cancer.

Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R. Traub F, et al. Among authors: von wasielewski r. Breast Cancer Res Treat. 2006 Sep;99(2):185-91. doi: 10.1007/s10549-006-9202-3. Epub 2006 Apr 25. Breast Cancer Res Treat. 2006. PMID: 16636894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page